Latest filing published 28 Mar 2024 for InnoCan Pharma Corporation.
No signal scores available.
All filings by Joshua Aaron Lintern on record concern InnoCan Pharma Corporation. In total, 4 filings cover trades dated from 25 September 2019 to 25 March 2024.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 28 March 2024 with a transaction in InnoCan Pharma Corporation. The median gap between a trade and its publication by SEDI is 16 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations